Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Don2018on Dec 20, 2019 1:28pm

222 Views

Post# 30477453

RE:10M Options Exercised in 2019

Tigerpuppy wrote: Did anybody get an answered as to who held the 10M incentive stock options that were exercised in 2019? Only 2.9M were exercised by insiders. I wonder if Mr. Brunner had a chunk of those.<br /> Maybe I will fly in for the AGM and ask that question.

Unfortunately that is private info outside of the insiders.

But I wouldn't doubt for a second that it is those people that have been selling and holding the share price down. That will end eventually, and could be the catalyst for a major move higher?

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal